ClinicalTrials.Veeva

Menu

Additional Hyperbaric Oxygen After Lower Extremity Amputation (AHOLEA)

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Enrolling

Conditions

Claudication, Intermittent
Diabetic Foot
Critical Limb Ischemia
Lower Extremity Ulcer
Diabetes Mellitus
Osteomyelitis
Diabetic Neuropathies
Amputation
Diabetic Angiopathy

Treatments

Procedure: Hyperbaric oxygen therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT03594344
2017/1587

Details and patient eligibility

About

This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment group receiving hyperbaric oxygen therapy, or control group.

Full description

Hyperbaric oxygen therapy has been used to treat hard to heal wounds for decades. Amputation, especially distal lower extremity amputations have the same problem with healing and patients often need to be re-amputated more proximally. In these patients oxygen levels are often the decisive factor. Providing additional oxygen under hyperbaric conditions will increase tissue oxygen concentration sufficient for the amputation stump to heal. This will give the patients a more distal amputation with better condition for ambulation.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Lower extremity amputation because of chronic wound, osteomyelitis, ischemia, necrosis.
  • Fit to receive hyperbaric oxygen therapy determined by an anesthesiologist/Hyperbaric Medicine Physician.
  • Able to cooperate and follow up appointments
  • Included within 7 days after final surgery

Exclusion criteria

  • Not fulfilling inclusion criteria
  • Pregnancy
  • Dementia

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 2 patient groups

Hyperbaric oxygen therapy
Experimental group
Description:
30 sessions of Hyperbaric oxygen therapy, 90min treatment at 2,4 ATA(atmosphere absolute) with 100% oxygen.First session must be given within 7 days after initial amputation. Treatment is given as outpatient treatment after discharge from hospital.
Treatment:
Procedure: Hyperbaric oxygen therapy
Control group
No Intervention group
Description:
Control group will be given standard of care with follow up at the outpatient clinic after discharge from hospital.

Trial contacts and locations

2

Loading...

Central trial contact

Elisabeth I Ellingsen Husebye, MD, PhD; Jonas Rydinge, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems